Story thread · 3 reports / 1 sources

Royal Unibrew A/S Non-GAAP EPS of DKK 11.00, revenue of DKK 4.43B; reaffirms FY 2026 outlook

seekingalpha.com · 1hShare

First report: Plus Therapeutics GAAP EPS of -$1.31 misses by $0.45; reaffirms FY outlook — seekingalpha.com, 1d